January 14, 2025 9:00 AM PST Milpitas, California, January 2025 – Applied StemCell, Inc., a proven CRO/CDMO and gene editing technology developer, is pleased to welcome Todd Garland to our Board of Directors and Mike Yurkovich as Vice President of Sales. Todd Garland brings over 30 years of expertise in product management, sales, and commercial […]
October 01, 2024 10:00 AM PST MILPITAS, Calif. – Applied StemCell, Inc. is proud to announce the successful approval of its latest U.S. patent which covers HLA-F engineered universal donor cells, marking a significant advancement in cell transplantation therapy and the first step towards an allogeneic cell therapy development platform. This innovation not only […]
December 04, 2023 9:00 AM PST MILPITAS, Calif.–Applied StemCell, Inc., a leading CRO/CDMO recognized for its proprietary TARGATT gene editing technology and expertise in stem cells and cell therapy development, is pleased to announce the addition of two accomplished professionals to its C-level executive team: George Hong (Chief Commercial Officer) and Timothy J. Largen […]
